When will AGT103-T be available for use?

AGT is working to facilitate the fastest possible progression of AGT103-T, but it is not possible to predict availability yet. The current focus is on proving that it can work to move HIV+ persons from antiretroviral therapy to a one-and-done functional cure.  Once that is established, we will move deliberately to bring it to patients in need, but the next steps will be determined based on data from the current phase 1 human trial. We hope to see data from phase 1 this year.